Distinctive Dynamics and Functions of the CD4+CD25+FOXP3+ Regulatory T Cell Population in Patients with Severe and Mild COVID-19
The Journal of Immunology · 2023
DOI: 10.4049/jimmunol.2200290 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Heejin Nam und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Center for Viral Immunology, Korea Virus Research Institute, Institute for Basic Science, Daejeon, Republic of Korea. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, COVID-19. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Institute for Basic Science.
Abstract (Originalsprache)
Although CD4+CD25+FOXP3+ regulatory T (TREG) cells have been studied in patients with COVID-19, changes in the TREG cell population have not been longitudinally examined during the course of COVID-19. In this study, we longitudinally investigated the quantitative and qualitative changes in the TREG cell population in patients with COVID-19. We found that the frequencies of total TREG cells and CD45RA−FOXP3hi activated TREG cells were significantly increased 15–28 d postsymptom onset in severe patients, but not in mild patients. TREG cells from severe patients exhibited not only increased proliferation but also enhanced apoptosis, suggesting functional derangement of the TREG cell population during severe COVID-19. The suppressive functions of the TREG cell population did not differ between patients with severe versus mild COVID-19. The frequency of TREG cells inversely correlated with SARS-CoV-2–specific cytokine production by CD4+ T cells and their polyfunctionality in patients with mild disease, suggesting that TREG cells are major regulators of virus-specific CD4+ T cell responses during mild COVID-19. However, such correlations were not observed in patients with severe disease. Thus, in this study, we describe distinctive changes in the TREG cell population in patients with severe and mild COVID-19. Our study provides a deep understanding of host immune responses upon SARS-CoV-2 infection in regard to TREG cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Center for Viral Immunology, Korea Virus Research Institute, Institute for Basic Science, Daejeon, Republic of Korea.
- Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
- Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Republic of Korea.
- Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.
- The Center for Epidemic Preparedness, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
ORCID-Profile: June-Young Koh, Hyeongseok Jeong, Hye Won Jeong, Eui-Cheol Shin
Förderung
- Institute for Basic Science
Zitieren
APA
Nam, H., Koh, J. Y., Jung, J. H., Jeong, H., Jeong, H. W., Cheon, S., Park, S. H., Kim, Y. S., & Shin, E. C. (2023). Distinctive Dynamics and Functions of the CD4+CD25+FOXP3+ Regulatory T Cell Population in Patients with Severe and Mild COVID-19. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2200290
Vancouver
Nam H, Koh JY, Jung JH, Jeong H, Jeong HW, Cheon S, et al. Distinctive Dynamics and Functions of the CD4+CD25+FOXP3+ Regulatory T Cell Population in Patients with Severe and Mild COVID-19. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2200290
BibTeX
@article{Nam2023,
author = {Nam, Heejin and Koh, June-Young and Jung, Jae Hyung and Jeong, Hyeongseok and Jeong, Hye Won and Cheon, Shinhye and Park, Su-Hyung and Kim, Yeon-Sook and Shin, Eui-Cheol},
title = {Distinctive Dynamics and Functions of the CD4+CD25+FOXP3+ Regulatory T Cell Population in Patients with Severe and Mild COVID-19},
journal = {The Journal of Immunology},
year = {2023},
doi = {10.4049/jimmunol.2200290}
}
EUVIMED